Impact of the COVID-19 outbreak on adjuvant chemotherapy for patients with stage II or III colon cancer: experiences from a multicentre clinical trial in China.
Impact of the COVID-19 outbreak on adjuvant chemotherapy for patients with stage II or III colon cancer: experiences from a multicentre clinical trial in China.
Curr Oncol. 2020 Jun;27(3):159-162
Authors: Sun L, Xu Y, Zhang T, Yang Y
PMID: 32669926 [PubMed - in process]
Source: Current Oncology - Category: Cancer & Oncology Tags: Curr Oncol Source Type: research
More News: Cancer | Cancer & Oncology | Chemotherapy | China Health | Clinical Trials | Colon Cancer | Colorectal Cancer | COVID-19 | Outbreaks